---
category: news
title: "TIGIT Blockade Could Be Key to Improving Success Rates in CAR T-Cell Therapy"
excerpt: "Single-cell transcriptional and phenotypic profiling of CAR T cells in patients who ultimately relapsed revealed high levels of immune checkpoint receptor TIGIT."
publishedDateTime: 2022-05-26T19:11:00Z
originalUrl: "https://www.precisiononcologynews.com/cancer/tigit-blockade-could-be-key-improving-success-rates-car-t-cell-therapy"
webUrl: "https://www.precisiononcologynews.com/cancer/tigit-blockade-could-be-key-improving-success-rates-car-t-cell-therapy"
type: article

provider:
  name: precisiononcologynews
  domain: precisiononcologynews.com

topics:
  - AI in Healthcare
  - AI

secured: "9YULcT32EkOiHycY5mZDnMhSnAiSxuEuPyLA5sTuEDGof+YomCN9vVwAJZ+hpWHV3XiMrlkJZetule6+TMhSQwdy7MG3hb9S9GYv1IS3DknKKnyWcD6/6qNOE8NiHxumVNgEqeo+GpaCb/N0j4oQu+bd3ADX+BWk3NmpA5ahXgcBCE2CBuJnpxcZElWFkehmQruYUWEBYUP1Th3OFvdU9OwMOOliY7j+vET03L3pA8Wka3ECL9n70JGhUCaLXzWDQiF8cFSIZ1NExLnIHhhWt3zoifQLEDa+uEH7QlIQNq7xTv7ffrCNCiYxXwKLdccoTaTNsS3OXUDp0cUecjU9Vwnu9L9p9gpwbMfESir5E5g=;OsR43YWz+xqnRf5RHFOtYw=="
---

